A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy
Nombre investigadores: Filip K Knop, Shweta Urva, Mallikarjuna Rettiganti, Charles T Benson, William C Roell, Kieren J Mather, Axel Haupt, Edward John Pratt
